S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/RTW Investments/Q2 2024

RTW Investments

Period: Q2 2024 Β· Filed: 2024-08-14
View on SEC EDGAR β†—
AUM
$6.46B
Total portfolio value
Positions
68
Reported securities
Top Holding
MDGL
8.3% $536.8M
QoQ Changes
+7 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-08-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
MDGLMADRIGAL PHARMACEUTICALS INC$536.8M8.31%$279.31$528.10+89.1%
8.3%
RCKTROCKET PHARMACEUTICALS INC$380.8M5.90%$20.66$3.84-81.4%
5.9%
AXSMAXSOME THERAPEUTICS INC$373.1M5.78%$81.03$244.31+201.5%
5.8%
RNAMAVIDITY BIOSCIENCES INC$359.8M5.57%β€”β€”
5.6%
ARGXARGENX SE$281.4M4.36%$434.22$939.68+116.4%
4.4%
NTRANATERA INC$280.8M4.35%$107.81$279.32+159.1%
4.3%
MRUSMERUS N V$246.7M3.82%β€”β€”
3.8%
INSMINSMED INC$243.9M3.78%$66.34$111.60+68.2%
3.8%
PTCTPTC THERAPEUTICS INC$226.1M3.50%$31.17$83.31+167.3%
3.5%
DYNDYNE THERAPEUTICS INC$225.4M3.49%$35.49$23.07-35.0%
3.5%
ACADACADIA PHARMACEUTICALS INC$222.8M3.45%$16.04$25.97+61.9%
3.5%
BRKRBRUKER CORP$219.8M3.40%$61.78$61.64-0.2%
3.4%
MASIMASIMO CORP$184.2M2.85%$116.40β€”
2.9%
PTGXPROTAGONIST THERAPEUTICS INC$183.2M2.84%$35.20$131.62+273.9%
2.8%
ALKSALKERMES PLC$170.1M2.63%$24.39$54.58+123.8%
2.6%
IMCRIMMUNOCORE HLDGS PLC$165.0M2.56%$36.43$32.50-10.8%
2.6%
CYTKCYTOKINETICS INC$147.4M2.28%$54.70$86.49+58.1%
2.3%
RAREULTRAGENYX PHARMACEUTICAL IN$134.0M2.07%$41.12$33.47-18.6%
2.1%
PENPENUMBRA INC$133.6M2.07%$177.09$318.57+79.9%
2.1%
AKROAKERO THERAPEUTICS INC$127.4M1.97%β€”β€”
2.0%
ESTAESTABLISHMENT LABS HLDGS INC$121.6M1.88%$43.34$89.25+105.9%
1.9%
IMTXIMMATICS N.V$116.2M1.80%$12.00$9.95-17.1%
1.8%
RDNTRADNET INC$109.4M1.69%$58.55$68.75+17.4%
1.7%
APGEAPOGEE THERAPEUTICS INC$106.7M1.65%$38.58$132.91+244.5%
1.6%
TARSTARSUS PHARMACEUTICALS INC$92.8M1.44%$28.24$65.44+131.7%
1.4%
ISRGINTUITIVE SURGICAL INC$90.1M1.39%$436.24$426.01-2.4%
1.4%
ARVNARVINAS INC$79.0M1.22%$25.98$8.39-67.7%
1.2%
SYRESPYRE THERAPEUTICS INC$76.6M1.19%$24.55$86.63+252.9%
1.2%
CRGXCARGO THERAPEUTICS INC$67.0M1.04%β€”β€”
1.0%
URGNUROGEN PHARMA LTD$59.7M0.92%$16.48$38.02+130.7%
0.9%

Quarter-on-Quarter Activity

Q2 2024 vs. Q1 2024

New Positions (7)

TickerIssuerNotional
CGEMCULLINAN THERAPEUTICS INC$18.4M
TEMTEMPUS AI INC$14.0M
REPLREPLIMUNE GROUP INC$10.2M
PCSCPERCEPTIVE CAP SOLUTIONS COR$7.5M
ABIOARCA BIOPHARMA INC$5.4M
GPCRSTRUCTURE THERAPEUTICS INC$4.9M
CTMXCYTOMX THERAPEUTICS INC$1.5M

Exited Positions (8)

TickerIssuerNotional
AVDLXXXXAVADEL PHARMACEUTICALS PLC$148.6M
SYKSTRYKER CORPORATION$114.9M
SWAVSHOCKWAVE MED INC$94.0M
TMOTHERMO FISHER SCIENTIFIC INC$64.2M
JANXJANUX THERAPEUTICS INC$37.6M
EXASEXACT SCIENCES CORP$6.6M
LRMRLARIMAR THERAPEUTICS INC$4.9M
XAIRBEYOND AIR INC$2.1M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
GKOSGLAUKOS CORP$40.2M+557.1%
MDGLMADRIGAL PHARMACEUTICALS INC$430.7M+382.5%+89.1%
CGONCG ONCOLOGY INC$24.3M+224.9%
DYNDYNE THERAPEUTICS INC$137.6M+106.6%-35.0%
ISRGINTUITIVE SURGICAL INC$50.5M+104.5%-2.4%
INSMINSMED INC$193.3M+95.2%+68.2%
SYRESPYRE THERAPEUTICS INC$-8.1M+45.9%+252.9%
NGNENEUROGENE INC$-0.2M+39.2%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
ACETADICET BIO INC$-8.4M-74.5%
TXG10X GENOMICS INC$-48.6M-67.7%
RAREULTRAGENYX PHARMACEUTICAL IN$-196.9M-54.0%-18.6%
VCELVERICEL CORP$-46.8M-50.1%
SGMTSAGIMET BIOSCIENCES INC$-3.7M-50.0%
IMCRIMMUNOCORE HLDGS PLC$-226.2M-19.1%-10.8%
SABSSAB BIOTHERAPEUTICS INC$-1.8M-16.4%
ARVNARVINAS INC$-57.1M-10.0%-67.7%
← Back to Hedge Funds